Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Although the deleterious vasoconstrictive effects of cell-free, hemoglobin-based blood substitutes have been appreciated, the systemic effects of chronic hemolysis on nitric oxide bioavailability have not been considered or quantified. Central to this investigation is the understanding that nitric oxide reacts at least 1,000 times more rapidly with free hemoglobin solutions than with erythrocytes. We hypothesized that decompartmentalization of hemoglobin into plasma would divert nitric oxide from homeostatic vascular function. We demonstrate here that plasma from patients with sickle-cell disease contains cell-free ferrous hemoglobin, which stoichiometrically consumes micromolar quantities of nitric oxide and abrogates forearm blood flow responses to nitric oxide donor infusions. Therapies that inactivate plasma hemoglobin by oxidation or nitric oxide ligation restore nitric oxide bioavailability. Decompartmentalization of hemoglobin and subsequent dioxygenation of nitric oxide may explain the vascular complications shared by acute and chronic hemolytic disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Priapism, nephropathy, and sickle vasculopathy are associated with hemolysis.”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“In these complications HbF has a less obvious beneficial effect, perhaps because only a small number of lysed sickle erythrocytes are needed to trigger these subphenotypes.59”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“As HbF falls and fewer F-cells are protected from HbS polymer damage, the propensity for vascular occlusion and intravascular hemolysis increases with the release of heme products into the circulation that scavenge nitric oxide causing endothelial damage and vasculopathy.[57][58][59]”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“A further consequence of sickling of cells is increased RBC hemolysis. Hemolysis affects not only the number of circulating RBCs but also release of Hb (and other cytoplasmic proteins) within the blood stream, thus profoundly affecting the viscosity and colloid properties of plasma and increasing systemic NO scavenging (71, 152).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [152]
In the citing paper
“For example, in hemolytic anemia, release of free Hb may lead to systemic NO scavenging, affecting vascular tone (71, 152).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [152]
Citations
Cites
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Identification of the haemoglobin scavenger receptor
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H.-J., Law, S. K. A., & Moestrup, S. K. (2001) · Nature · doi:10.1038/35051594 · Cited by 1,712
Mechanism of NO-induced oxidation of myoglobin and hemoglobin
Eich, R. F., Li, T., Lemon, D. D., Doherty, D. H., Curry, S. R., Aitken, J. F., Mathews, A. J., Johnson, K. A., Smith, R. D., Phillips, et al. (1996) · Biochemistry · doi:10.1021/bi960442g · Cited by 613
Diffusion-limited reaction of free nitric oxide with erythrocytes
Liu, X., Miller, M. J. S., Joshi, M. S., Sadowska-Krowicka, H., Clark, D. A., & Lancaster, J. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18709 · Cited by 512
A Tutorial on the Diffusibility and Reactivity of Free Nitric Oxide
Lancaster, J. R. (1997) · Nitric Oxide · doi:10.1006/niox.1996.0112 · Cited by 495
Nitric oxide in the human respiratory cycle
McMahon, T. J., Moon, R. E., Luschinger, B. P., Carraway, M. S., Stone, A. E., Stolp, B. W., Gow, A. J., Pawloski, J. R., Watke, P., Singel, D. J., et al. (2002) · Nature Medicine · doi:10.1038/nm718 · Cited by 469
Gladwin, M. T., Shelhamer, J. H., Schechter, A. N., Pease-Fye, M. E., Waclawiw, M. A., Panza, J. A., Ognibene, F. P., & Cannon, R. O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11482 · Cited by 441
Self-citationRate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin
Doherty, D. H., Doyle, M. P., Curry, S. R., Vali, R. J., Fattor, T. J., Olson, J. S., & Lemon, D. D. (1998) · Nature Biotechnology · doi:10.1038/nbt0798-672 · Cited by 432
Autoxidation kinetics of aqueous nitric oxide
Ford, P. C., Wink, D. A., & Stanbury, D. M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81748-o · Cited by 419
Research works printed but not linked: 3
- Vaughn, M.W., Kuo, L. & Liao, J.C. Effective diffusion distance of nitric oxide in the microcirculation. Am. J. Physiol. 274, H1705–H1714 (1998).
- Vogel, W.M., Dennis, R.C., Cassidy, G., Apstein, C.S. & Valeri, C.R. Coronary constrictor effect of stroma-free hemoglobin solutions. Am. J. Physiol. 251, H413–H420 (1986).
- Pohl, U. & Lamontagne, D. Impaired tissue perfusion after inhibition of endothelium-derived nitric oxide. Basic Res. Cardiol. 86, 97–105 (1991).
Cited by
Items 301–400 of 1,000
Pleiotropic effects of intravascular haemolysis on vascular homeostasis
Kato, G. J., & Taylor, J. G. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08004.x · Cited by 87
Nitric Oxide Transport in Blood: A Third Gas in the Respiratory Cycle
Doctor, A., & Stamler, J. S. (2011) · Comprehensive physiology · doi:10.1002/cphy.c090009 · Cited by 85
Hahl, P., Davis, T., Washburn, C., Rogers, J. T., & Smith, A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12165 · Cited by 77
Alapan, Y., Kim, C., Adhikari, A., Gray, K. E., Gürkan-Çavusoglu, E., Little, J. A., & Gurkan, U. A. (2016) · Translational research · doi:10.1016/j.trsl.2016.03.008 · Cited by 85
“Hemoglobin and arginase released from RBCs during hemolysis result in decreased nitric oxide bioactivity, affecting vascular tone and endothelial activation.(134,138) Markers of hemolysis in blood, such as LDH, have been associated with elevated soluble adhesion molecules in plasma, including Vascular Cell Adhesion Mo…”
BackgroundHugelshofer, M., Buzzi, R. M., Schaer, C. A., Richter, H., Akeret, K., Anagnostakou, V., Mahmoudi, L., Vaccani, R., Vallelian, F., Deuel, J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130630 · Cited by 81
Catalase-Mediated Nitric Oxide Formation from Hydroxyurea
Huang, J., Kim‐Shapiro, D. B., & King, S. B. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030547z · Cited by 77
Tremblay, J. C., Hoiland, R. L., Howe, C. A., Coombs, G. B., Vizcardo‐Galindo, G. A., Figueroa‐Mujíca, R., Bermúdez, D., Gibbons, T. D., Stacey, B. S., Bailey, D. M., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12780 · Cited by 76
Buys, E. S., Zimmer, D. P., Chickering, J. G., Graul, R. M., Chien, Y., Profy, A. T., Hadcock, J. R., Masferrer, J. L., & Milne, G. T. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.05.009 · Cited by 82
The molecular basis for the prothrombotic state in sickle cell disease
Shet, A. S., Lizarralde-Iragorri, M. A., & Naik, R. P. P. (2020) · Haematologica · doi:10.3324/haematol.2019.239350 · Cited by 85
Basic Mechanisms of Hemolysis-Associated Thrombo-Inflammation and Immune Dysregulation
Dimitrov, J. D., Roumenina, L. T., Perrella, G., & Rayes, J. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.318780 · Cited by 78
Pulmonary Hypertension in Hemolytic Disorders
Machado, R. F., & Gladwin, M. T. (2010) · CHEST Journal · doi:10.1378/chest.09-3057 · Cited by 82
Self-citationLipiski, M., Deuel, J., Baek, J. H., Engelsberger, W. R., Buehler, P. W., & Schaer, D. J. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5089 · Cited by 79
“This is consistent with previously published data using the same assay to confirm NO consumption in hemolysing sickle cell patient blood/plasma (35) and in previous studies showing equivalent NO consumption with the Hb:Hp complex (4).”
Nitric oxide bioavailability in malaria
Sobolewski, P., Gramaglia, I., Frangos, J. A., Intaglietta, M., & van der Heyde, H. C. (2005) · Trends in Parasitology · doi:10.1016/j.pt.2005.07.002 · Cited by 74
The role of red blood cells and cell-free hemoglobin in the pathogenesis of ARDS
Janz, D. R., & Ware, L. B. (2015) · Journal of Intensive Care · doi:10.1186/s40560-015-0086-3 · Cited by 81
“In patients with sickle cell disease, a condition characterized by intravascular hemolysis and release of up to 30 grams of CFH from the RBC per day, increases in plasma heme were strongly correlated with an increase in NO consumption and peripheral vasoconstriction which could be reversed with inhaled NO [27].”
BackgroundAutologous Transfusion of Stored Red Blood Cells Increases Pulmonary Artery Pressure
Berra, L. M., Pinciroli, R., Stowell, C. P., Wang, L., Yu, B., Fernandez, B. O., Feelisch, M., Mietto, C., Hod, E. A., Chipman, D., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201405-0850oc · Cited by 74
Anosike, C. A., Igboegwu, O. N., & Nwodo, O. F. C. (2018) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2017.08.002 · Cited by 74
AAAPT Diagnostic Criteria for Acute Sickle Cell Disease Pain
Field, J. J., Ballas, S. K., Campbell, C. M., Crosby, L. E., Dampier, C., Darbari, D. S., McClish, D. K., Smith, W. R., & Zempsky, W. T. (2018) · Journal of Pain · doi:10.1016/j.jpain.2018.12.003 · Cited by 74
Widmer, C. C., Pereira, C. P., Gehrig, P., Vallelian, F., Schoedon, G., Buehler, P. W., & Schaer, D. J. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2826 · Cited by 72
“nitric oxide by the dioxygenase reaction is likely to be involved in the vasoconstrictive and hypertensive properties of Hb (34).”
BackgroundCURAMA study group, Schnog, J. B., Teerlink, T., van der Dijs, F. P. L., Duits, A. J., & Muskiet, F. A. J. (2004) · Annals of Hematology · doi:10.1007/s00277-004-0983-3 · Cited by 73
“Inverse relations of NOx to sVCAM-1 levels have been reported in SCD, and it is interesting to speculate that NOS inhibition by ADMA contributes to these findings [ 10 , 24].”
Porter, J. B. (2009) · Hemoglobin · doi:10.3109/03630260903346627 · Cited by 73
“Plasma heme is known to be higher in SCD than in controls (60), and circulating endothelial cells express three times increased HO1 in SCD than in controls (61).”
BackgroundEndothelial activation and dysregulation in malaria: a potential target for novel therapeutics
Kim, H., Higgins, S. J., Liles, W. C., & Kain, K. C. (2011) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328345a4cf · Cited by 76
Pulmonary hypertension associated with thalassemia syndromes
Fraidenburg, D. R., & Machado, R. F. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13037 · Cited by 73
Molecular Controls of the Oxygenation and Redox Reactions of Hemoglobin
Bonaventura, C., Henkens, R. W., Alayash, A. I., Banerjee, S., & Crumbliss, A. L. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4947 · Cited by 78
“This substitution alters Hb’s behavior in vivo and is the molecular basis of sickle cell disease (SCD) and associated circulatory problems (see Redox activity of sickle cell Hb and the mechanism of malarial defense section) (78, 97).”
BackgroundNiu, X., Nouraie, M. S., Campbell, A., RANA, S. R., Minniti, C. P., Sable, C., Darbari, D. S., Dham, N., Reading, N. S., Prchal, J. T., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007956 · Cited by 71
“Intravascular hemolysis contributes to a hemolytic vasculopathy in part through scavenging nitric oxide, a key modulator of microvascular function [11], and through limiting availability of arginine, the substrate for nitric oxide synthase [12].”
BackgroundSelf-citationSickle cell disease in the older adult
Thein, M. S., Igbineweka, N. E., & Thein, S. L. (2016) · Pathology · doi:10.1016/j.pathol.2016.10.002 · Cited by 104
“Chronic NO deficiency can lead to platelet activation, increased vascular resistance, and endothelial dysfunction contributing to the development of vasculopathy.(36,37) Ongoing haemolytic anaemia arises from the shortened lifespan of sickled erythrocytes of 16–20 days compared to normal of 120 days.”
Effects of Aged Stored Autologous Red Blood Cells on Human Endothelial Function
Risbano, M. G., Kanias, T., Triulzi, D. J., Donadee, C., Barge, S., Badlam, J. B., Jain, S., Belanger, A., Kim‐Shapiro, D. B., & Gladwin, M. T. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0145oc · Cited by 74
“We have previously shown that small amounts of CFPHb result in reduced NO bioavailability with levels as low as 1 mM in kinetic models and 6 mM in animal models (32, 43).”
BackgroundSelf-citationDetterich, J. A., Kato, R. M., Rábai, M., Meiselman, H. J., Coates, T. D., & Wood, J. C. (2015) · Blood · doi:10.1182/blood-2014-12-614370 · Cited by 71
Pulmonary Complications of Hemoglobinopathies
Vij, R., & Machado, R. F. (2010) · CHEST Journal · doi:10.1378/chest.10-0317 · Cited by 74
Zuzak, K. J., Gladwin, M. T., Cannon, R. O., & Levin, I. W. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00243.2003 · Cited by 72
Self-citationMeegan, J. E., Bastarache, J. A., & Ware, L. B. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00018.2021 · Cited by 75
Pulmonary hypertension in thalassemia
Morris, C. R., & Vichinsky, E. P. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05580.x · Cited by 71
Plasma Free Hemoglobin and Microcirculatory Response to Fresh or Old Blood Transfusions in Sepsis
Damiani, E., Adrario, E., Luchetti, M. M., Scorcella, C., Carsetti, A., Mininno, N., Pierantozzi, S., Principi, T., Strovegli, D., Bencivenga, R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122655 · Cited by 69
“fHb is a potent scavenger of nitric oxide (NO), the most important endogenous vasodilator [9], and may therefore be responsible for microvascular perfusion disturbances [10].”
BackgroundNitric oxide and blood: a review
Wallis, J. P. (2005) · Transfusion Medicine · doi:10.1111/j.1365-3148.2005.00542.x · Cited by 66
“It is suggested that such scavenging of NO contributes to the hypertensive and thrombotic tendency in sickle cell disease and other disorders with intravascular haemolysis (Reiter et al., 2002).”
BackgroundA Genome-Wide Association Study of Total Bilirubin and Cholelithiasis Risk in Sickle Cell Anemia
Milton, J. N., Sebastiani, P., Solovieff, N., Hartley, S. W., Bhatnagar, P., Arking, D. E., Dworkis, D. A., Casella, J. F., Barron‐Casella, E. A., Bean, C. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034741 · Cited by 67
Self-citationLactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia
Gurkan, S., Scarponi, K. J., Hotchkiss, H., Savage, B. A., & Drachtman, R. A. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1560-8 · Cited by 72
Dubert, M., Élion, J., Tolo, A., Diallo, D. A., Diop, S., Diagne, I., Sanogo, I., Belinga, S., Guifo, O., Wamba, G., et al. (2017) · Blood · doi:10.1182/blood-2016-12-755777 · Cited by 73
Pulmonary Hypertension in Lambs Transfused with Stored Blood Is Prevented by Breathing Nitric Oxide
Baron, D. M., Yu, B., Lei, C., Bagchi, A., Beloiartsev, A., Stowell, C. P., Steinbicker, A. U., Malhotra, R. K., Bloch, K. D., & Zapol, W. M. (2012) · Anesthesiology · doi:10.1097/aln.0b013e318246ef77 · Cited by 69
Measurement of Posttransfusion Red Cell Survival With the Biotin Label
Mock, D. M., Widness, J. A., Veng‐Pedersen, P., Strauss, R. G., Cancelas, J. A., Cohen, R. M., Lindsell, C. J., & Franco, R. S. (2014) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2014.03.003 · Cited by 73
“Buchta et al [91] 7 Autologous 2/5 [52-81] No”
BackgroundOh, J., Hamm, J. D., Xu, X., Genschmer, K. R., Zhong, M., Lebensburger, J. D., Marques, M. B., Kerby, J. D., Pittet, J., Gaggar, A., et al. (2016) · Redox Biology · doi:10.1016/j.redox.2016.08.003 · Cited by 69
Emerging point-of-care technologies for sickle cell disease screening and monitoring
Alapan, Y., Fraiwan, A., Kucukal, E., Hasan, M. N., Ung, R., Kim, M., Odame, I., Little, J. A., & Gurkan, U. A. (2016) · Expert Review of Medical Devices · doi:10.1080/17434440.2016.1254038 · Cited by 71
“Importantly, intravascular heme arising from hemolysis impairs endothelial cell function and vascular tone, while triggering WBC activation, inflammation, and activation of coagulation [94 – 98].”
BackgroundThe Role of Circulating Cell-Free Hemoglobin in Sepsis-Associated Acute Kidney Injury
Kerchberger, V. E., & Ware, L. B. (2020) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2020.01.006 · Cited by 67
Nader, É., Romana, M., Guillot, N., Fort, R., Stauffer, É., Lemonne, N., Garnier, Y., Skinner, S. C., Etienne‐Julan, M., Robert, M., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.551441 · Cited by 75
Prabhakar, H., Haywood, C., & Molokie, R. E. (2010) · American Journal of Hematology · doi:10.1002/ajh.21676 · Cited by 71
“Several studies have demonstrated that inhaled NO decreases pulmonary hypertension in children and adults [71,72].”
BackgroundPriapism in Sickle-Cell Disease: A Hematologist’s Perspective
Kato, G. J. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02287.x · Cited by 71
Bastarache, J. A., Sebag, S. C., Clune, J. K., Grove, B. S., Lawson, W. E., Janz, D. R., Roberts, L. J., Dworski, R., Mackman, N., & Ware, L. B. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-201781 · Cited by 65
Nitric oxide from nitrite reduction by hemoglobin in the plasma and erythrocytes
Chen, K., Piknova, B., Pittman, R. N., Schechter, A. N., & Popel, A. S. (2007) · Nitric Oxide · doi:10.1016/j.niox.2007.09.088 · Cited by 71
Self-citationHaldane, hot dogs, halitosis, and hypoxic vasodilation: the emerging biology of the nitrite anion
Gladwin, M. T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420664 · Cited by 67
Self-citationA disposable microfluidic-integrated hand-held plasmonic platform for protein detection
İnci, F., Saylan, Y., Mataji‐Kojouri, A., Ogut, M. G., Denizli, A., & Demirci, U. (2019) · Applied Materials Today · doi:10.1016/j.apmt.2019.100478 · Cited by 67
“evel is less than 20 M, indicating that the elevated levels of ell-free plasma hemoglobin limits nitric oxide-mediated vasodiation in patients with sickle cell disease [17].”
BackgroundAllali, S., Rignault‐Bricard, R., de Montalembert, M., Taylor, M., Bouceba, T., Hermine, O., & Maciel, T. T. (2022) · Blood · doi:10.1182/blood.2021014894 · Cited by 67
Ataga, K. I., Brittain, J. E., Moore, D. F., Jones, S., Hulkower, B., Strayhorn, D., Adam, S. S., Redding‐Lallinger, R., Nachman, P. H., & Orringer, E. P. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01471.x · Cited by 71
“While the pathogenesis of SCD-associated PHT is probably multifactorial, there is evidence that chronic intravascular hemolysis, with subsequent destruction of nitric oxide by cell-free plasma hemoglobin, plays a central role in this complication (1, 5, 6).”
BackgroundInflammatory Mediators of Endothelial Injury in Sickle Cell Disease
Hoppe, C. C. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.11.006 · Cited by 74
Sodium nitrite promotes regional blood flow in patients with sickle cell disease: a phase I/II study
Mack, A. K., McGowan II, V. R., Tremonti, C. K., Ackah, D., Barnett, C., Machado, R. F., Gladwin, M. T., & Kato, G. J. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07259.x · Cited by 64
“…resulting from intravascular haemolysis in patients with SCD rapidly consumes NO, causing a state of functional resistance to NOdependent vasodilation (Kaul et al, 2000, 2004; Nath et al, 2000; Belhassen et al, 2001; Reiter et al, 2002; Eberhardt et al, 2003; de Montalembert et al, 2007).”
BackgroundResultSelf-citationAtorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms
de Castro, M. M., Rizzi, É., Rascado, R. R., Nagassaki, S., Bendhack, L. M., & Tanus-Santos, J. E. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.051 · Cited by 64
Self-citationVoskaridou, E., Tsetsos, G., Tsoutsias, A., Spyropoulou, E., Christoulas, D., & Terpos, E. (2007) · Haematologica · doi:10.3324/haematol.11136 · Cited by 63
“Age (years) 35 (21-62) 35 (20-60) Gender (n) 31M/53F 5M/10F Interacting β 39 (38), β-thalassemia genes (n) IVS1-1 (11), FSC8 (2), − IVS1-110 (24), IVS1-6 (9)”
InfluentialPulmonary hypertension and NO in sickle cell
Gladwin, M. T., Barst, R. J., Castro, O. L., Gordeuk, V. R., Hillery, C. A., Kato, G. J., Kim-Shapiro, D. B., Machado, R., Morris, C. R., Steinberg, M. H., et al. (2010) · Blood · doi:10.1182/blood-2010-04-282095 · Cited by 65
Self-citationPulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Klings, E. S., & Farber, H. W. (2004) · New England Journal of Medicine · doi:10.1056/nejm200406103502418 · Cited by 64
Machado, R. F., Hildesheim, M., Mendelsohn, L., Remaley, A. T., Kato, G. J., & Gladwin, M. T. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08777.x · Cited by 64
Self-citationArumugam, P. I., Mullins, E. S., Shanmukhappa, S. K., Monia, B. P., Loberg, A., Shaw, M. A., Rizvi, T., Wansapura, J., Degen, J. L., & Malik, P. (2015) · Blood · doi:10.1182/blood-2015-01-625707 · Cited by 59
“It is characterized by erythrocyte sickling, chronic hemolytic anemia, episodic acute vaso-occlusions, chronic systemic inflammation at baseline, and acute and chronic cumulative organ damage.(1-7) Therapeutic options to prevent organ pathologies are limited to chronic transfusions, hydroxyurea, or an allogeneic hemat…”
BackgroundRevisiting the putative role of heme as a trigger of inflammation
Vallelian, F., Schaer, C. A., Deuel, J., Ingoglia, G., Humar, R., Buehler, P. W., & Schaer, D. J. (2018) · Pharmacology Research & Perspectives · doi:10.1002/prp2.392 · Cited by 64
Enzyme Mimics for the Catalytic Generation of Nitric Oxide from Endogenous Prodrugs
Yang, T., Zelikin, A. N., & Chandrawati, R. (2020) · Small · doi:10.1002/smll.201907635 · Cited by 67
Liem, R. I., Young, L. T., & Thompson, A. A. (2007) · Haematologica · doi:10.3324/haematol.11576 · Cited by 67
“Reiter et al.(10) demonstrated that plasma from patients with SCD inactivates NO.”
BackgroundAnele, U. A., & Burnett, A. L. “. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12816 · Cited by 63
“Chronically decreased NO bioavailability, an environment influenced from multiple sources in SCD [22, 23], may offer an explanation for the differing ED development rates between SCD and non-SCD populations.”
BackgroundRed blood cell transfusion in critically ill children: A narrative review*
Istaphanous, G. K., Wheeler, D. S., Lisco, S. J., & Shander, A. (2010) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3181e30d09 · Cited by 62
“Finally, the small quantity of free Hb always present in banked RBC units quickly binds endogenously produced nitric oxide (16), resulting in vasoconstriction of small vessels and ultimately decreasing local ḊO2 at the tissue level.”
BackgroundAtaga, K. I., & Stocker, J. W. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802708011 · Cited by 62
“Hemolysis seems to predispose SCD patients (and perhaps patients with other chronic hemolytic anemias) to a vasculopathy that may manifest as one or more of several complications including pulmonary hypertension, leg ulcers, priapism, stroke and glomerulopathy [3,7-10] .”
BackgroundLiem, R. I., Reddy, M. G., Pelligra, S. A., Savant, A. P., Fernhall, B., Rodeghier, M., & Thompson, A. A. (2015) · Physiological Reports · doi:10.14814/phy2.12338 · Cited by 63
“Sickle cell anemia (SCA) is a common inherited blood disorder associated with abnormal hemoglobin production and characterized by chronic hemolysis, a proinflammatory state and endothelial dysfunction (Solovey et al. 1997; Reiter et al. 2002; Hebbel et al. 2004; Brittain and Parise 2007).”
BackgroundMinneci, P. C., Deans, K. J., Shiva, S., Zhi, H., Banks, S. M., Kern, S., Natanson, C., Solomon, S. B., & Gladwin, M. T. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00151.2008 · Cited by 60
Self-citationEnhanced Pulmonary and Systemic Response to Endotoxin in Transgenic Sickle Mice
Holtzclaw, J. D., Jack, D., Aguayo, S. M., Eckman, J. R., Roman, J., & Hsu, L. L. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200302-224oc · Cited by 61
Suhr, F., Porten, S., Hertrich, T., Brixius, K., Schmidt, A., Platen, P., & Bloch, W. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.10.004 · Cited by 62
Gordeuk, V. R., Campbell, A., Rana, S., Nouraie, M., Niu, X., Minniti, C. P., Sable, C., Darbari, D., Dham, N., Onyekwere, O., et al. (2009) · Blood · doi:10.1182/blood-2009-04-218040 · Cited by 63
Self-citationLongitudinal follow up of elevated pulmonary artery pressures in children with sickle cell disease
Pashankar, F. D., Carbonella, J., Bazzy‐Asaad, A., & Friedman, A. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07501.x · Cited by 62
“Impairment of NO bioavailability over decades leads to chronic vasoconstriction and mild pulmonary hypertension (Reiter et al, 2002; Gladwin et al, 2004; Morris et al, 2005; Rother et al, 2005).”
Backgroundl-Arginine attenuates acute pulmonary embolism-induced oxidative stress and pulmonary hypertension
Souza-Costa, D. C., Zerbini, T., Metzger, I. F., da Rocha, J. B. T., Gerlach, R. F., & Tanus-Santos, J. E. (2004) · Nitric Oxide · doi:10.1016/j.niox.2004.10.009 · Cited by 61
Self-citationWester-Rosenlöf, L., Casslén, V., Axelsson, J., Anneli, E.-H., Gram, M., Holmqvist, M., Johansson, M., Larsson, I., Ley, D., Maršál, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086353 · Cited by 66
“Free Hb is well known to have pro-inflammatory, pro-oxidative, tissue damaging and vasoconstrictive properties [9,10].”
BackgroundTaylor, J. G., Ackah, D., Cobb, C., Orr, N., Percy, M. J., Sachdev, V., Machado, R., Castro, O., Kato, G. J., Chanock, S. J., et al. (2008) · American Journal of Hematology · doi:10.1002/ajh.21035 · Cited by 60
Self-citationClinical differences between children and adults with pulmonary hypertension and sickle cell disease
Hagar, R. W., Michlitsch, J., Gardner, J. L., Vichinsky, E. P., & Morris, C. R. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06822.x · Cited by 65
“Haemoglobin is released during intravascular haemolysis and scavenges NO (Reiter et al, 2002; Azarov et al, 2005; Hsu et al, 2007) while the simultaneous release of erythrocyte arginase (Morris et al, 2005a) consumes arginine, the substrate for NO synthesis.”
BackgroundVasoactivity of S-nitrosohemoglobin: role of oxygen, heme, and NO oxidation states
Crawford, J. H., White, C. R., & Patel, R. P. (2003) · Blood · doi:10.1182/blood-2002-12-3825 · Cited by 60
Role of the Red Blood Cell in Nitric Oxide Homeostasis and Hypoxic Vasodilation
Gladwin, M. T. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-34817-9_17 · Cited by 59
Self-citationHankins, J. S., McCarville, M. B., Hillenbrand, C. M., Loeffler, R. B., Ware, R. E., Song, R., Smeltzer, M. P., & Joshi, V. M. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22587 · Cited by 59
“The ongoing intravascular hemolysis that occurs in SCA rapidly inactivates NO via consumption by cell-free hemoglobin and also by a reaction between ferrous iron and ferric iron that forms nitrosylhemoglobin, which consumes NO [36].”
BackgroundInhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease
Noomuna, P., Risinger, M. A., Zhou, S., Seu, K. G., Man, Y., An, R., Sheik, D. A., Wan, J., Little, J. A., Gurkan, U. A., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16671 · Cited by 62
“in agreement with previous studies.(12,15,24,47) Moreover, the number of MPs, identified as glycophorin A positive particles of 0 1–1 0 μm diameter (Figure S2), were also more than twice as abundant in patients than in healthy volunteers (panel B), and therefore also consistent with previous observations(14) by(12,15,…”
ResultLandburg, P. P., Teerlink, T., Biemond, B. J., Brandjes, D. P. M., Muskiet, F. A. J., Duits, A. J., & Schnog, J. B. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.02.005 · Cited by 64
Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease
Desai, P. C., Deal, A. M., Pfaff, E., Qaqish, B. F., Hebden, L. M., Park, Y. A., & Ataga, K. I. (2015) · American Journal of Hematology · doi:10.1002/ajh.24051 · Cited by 63
“that normally neutralizes the oxidative and inflammatory effects of heme [24]; increased plasma non-transferrin-bound iron, which may lead to increased risk of sepsis and possibly mortality [25]; higher RBC membrane loss, which may result in phospholipid changes, and the release of microparticles (which are considered…”
BackgroundStandards for the Clinical Care of Children and Adults with Thalassaemia in the UK
Yardumian, A., Telfer, P. T., Constantinou, G., Darbyshire, P., Darlison, M. W., Kinsey, S. E., Miller, E. P., Modell, B., Pollitzer, M. J., & Porter, J. B. (2005) · UCL Discovery (University College London) · Cited by 62
Increased soluble guanylate cyclase activity in the red blood cells of sickle cell patients
Conran, N., dos Santos, C. O., Acosta, H. C., Fattori, A., Saad, S. T. O., & Costa, F. F. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04810.x · Cited by 65
“…for activation of sGC may be elevated in the sickle RBC somewhat contradicts the recent finding that the bioavailability of NO is reduced in the plasma of SCD patients, due to the scavenging of NO by the increased levels of cell-free haemoglobin released from lysed RBC (Reiter et al, 2002).”
BackgroundResultA Global Perspective on the Epidemiology of Pulmonary Hypertension
Mocumbi, A. O., Thienemann, F., & Sliwa, K. S. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.01.030 · Cited by 60
Cho, C., Kato, G. J., Yang, S. H., Bae, S. W., Lee, J. S., Gladwin, M. T., & Rhee, S. G. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2978 · Cited by 69
“…now appreciated that chronic intravascular hemolysis increases nitric oxide (NO) scavenging and endothelial dysfunction, leading to a progressive systemic vasculopathy, including pulmonary hypertension, cutaneous leg ulceration, priapism, and association with a high risk of death (2, 12, 40, 44).”
Self-citationPavenski, K., Saidenberg, E., Lavoie, M., Tokessy, M., & Branch, D. R. (2011) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2011.07.003 · Cited by 60
Vascular Effects of the Red Blood Cell Storage Lesion
Roback, J. D. (2011) · Hematology · doi:10.1182/asheducation-2011.1.475 · Cited by 61
eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population
Nagassaki, S., Metzger, I. F., Souza-Costa, D. C., Marroni, A. S., Uzuelli, J. A., & Tanus-Santos, J. E. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.09.003 · Cited by 57
Self-citationScope of the problem: epidemiology of anemia and use of blood transfusions in critical care.
Napolitano, L. M. (2004) · Critical Care · doi:10.1186/cc2832 · Cited by 57
“Other potential adverse effects related to allogeneic blood transfusion have been identified, including increased risk for nosocomial infection [14], inflammatory response [15], pulmonary and systemic vasoconstriction related to age of blood and nitric oxide binding [16,17], and immunosuppression [18].”
BackgroundMixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis
Wu, C. J., Gladwin, M., Tisdale, J., Hsieh, M., Law, T., Biernacki, M., Rogers, S., Wang, X., Walters, M., Zahrieh, D., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06803.x · Cited by 57
“The median pretransplant values for indices of intravascular haemolysis of our cohort were elevated, similar to the general SCD population (Reiter et al, 2002).”
BackgroundSelf-citationMechanisms of Slower Nitric Oxide Uptake by Red Blood Cells and Other Hemoglobin-containing Vesicles
Azarov, I., Liu, C., Reynolds, H., Tsekouras, Z., Lee, J. S., Gladwin, M. T., & Kim‐Shapiro, D. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228650 · Cited by 58
Self-citationAlterations of the Arginine Metabolome in Sickle Cell Disease
Morris, C. R. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.11.008 · Cited by 59
Hydroxyurea Generates Nitric Oxide in Human Erythroid Cells: Mechanisms for γ-Globin Gene Activation
Lou, T., Singh, M., Mackie, A., Li, W., & Pace, B. S. (2009) · Experimental Biology and Medicine · doi:10.3181/0811-rm-339 · Cited by 67
“Reiter and colleagues (19) demonstrated that NO levels decrease in patients with chronic hemolytic anemia via consumption by free plasma hemoglobin.”
BackgroundSchaer, C. A., Vallelian, F., Imhof, A., Schoedon, G., & Schaer, D. J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0706453 · Cited by 55
McArthur, J. G., Svenstrup, N., Chen, C., Fricot, A., Carvalho, C., Nguyen, J., Nguyen, P., Parachikova, A. I., Abdulla, F. A., Vercellotti, G. M., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.213462 · Cited by 56
“nitric oxide (NO) and promotes vasoconstriction, which further alters vascular biology.(8-10) This process in turn promotes the activation and mobilization of white blood cells (WBC), increasing their adhesiveness to activated endothelium.”
BackgroundThe potential adverse effects of haemolysis.
Rapido, F. (2017) · Europe PMC (PubMed Central) · doi:10.2450/2017.0311-16 · Cited by 70
Hu, J., Spina, S., Zadek, F., Олегович, К. Н., Bittner, E. A., Pedemonte, J. C., & Berra, L. M. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0605-9 · Cited by 56
“Nitric oxide is a potent endogenous vasodilator released by endothelial cells and its depletion leads to vasoconstriction, and ultimately to reduce organ perfusion [17, 35, 36].”
BackgroundCurrent and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease
Osunkwo, I., Manwani, D. G., & Kanter, J. (2020) · Therapeutic Advances in Hematology · doi:10.1177/2040620720955000 · Cited by 64
Yallop, D., Duncan, E. R., Norris, E., Fuller, G. W., Thomas, N., Walters, J., Dick, M. C., Height, S. E., Thein, S. L., & Rees, D. C. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06493.x · Cited by 56
“It was suggested that impaired bioavailability of NO in SCD is due in part to the scavenging of NO by cell free plasma haemoglobin (Reiter et al, 2002).”
BackgroundJison, M. L., & Gladwin, M. T. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2304002 · Cited by 59
Self-citationGhosh, S., Tan, F., & Ofori-Acquah, S. F. (2012) · Anemia · doi:10.1155/2012/582018 · Cited by 56
Metadata
- Authors
- Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T.
- Affiliations
- National Institutes of Health (US)
- Medical College of Wisconsin (US)
- Corresponding author
- Gladwin, Mark T.
- Venue
- Nature Medicine
- Published
- 2002-11-11
- Volume
- 8
- Issue
- 12
- Pages
- 1383-1389
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4241694836
- Semantic Scholar
- 80bbf9611dbe14c7276b2a4dbca6e42007866746
- Cited by
- 1,330
- References
- 45
- Citations by year
- 2026: 44 · 2025: 39 · 2024: 45 · 2023: 39 · 2022: 57 · 2021: 55 · 2020: 56 · 2019: 59 · 2018: 60 · 2017: 45 · 2016: 62 · 2015: 63 · 2014: 69 · 2013: 68 · 2012: 68
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM55792)
- National Center for Research Resources (P41RR001008, RR 01008)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- free hemoglobin, nitric oxide bioavailability, sickle cell disease, chronic hemolysis, plasma hemoglobin, forearm blood flow, hemoglobin oxidation, vasoconstriction
- MeSH terms
- Adult, Anemia, Sickle Cell, Biological Availability, Heme, Hemocyanins, Hemoglobins, Hemolysis, Humans, Middle Aged, Nitric Oxide, Oxidation-Reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.